DP antagonist
US11319296B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2019 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | Sep 19, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a DP receptor antagonist. A compound represented by general formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.